Skip to content

Total Assets at other companies

Amgen logo
AmgenAMGN
$92.5B+3.5%
Moderna logo
ModernaMRNA
$11.49B-9.6%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$957.01M+23.3%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Regenxbio logo
RegenxbioRGNX
$341.89M-30.4%

Other financials

Income statement

See full
Revenue$2.5M-66.7%
Operating income-$339.2M-23.6%
Net income-$265.9M-257%
EPS (diluted)-$0.38-265%

Balance sheet

See full
Cash & equivalents$1.4B+1,411%
Total debt$107.4M+7.3%
Total equity$4.5B-3.4%

Cash flow

See full
Operating cash flow-$163.8M+5.1%
CapEx$1.3M+55.5%
Free cash flow-$165.1M+4.8%

Valuation

See full
Market cap$25.45B+220%
Enterprise value$24.14B+204%
P/S3,081.7×+2,740×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-9,183.5%-17,093pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio18.4×-15.1×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Roivant Sciences’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Roivant Sciences's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Roivant Sciences's total assets?
Roivant Sciences (ROIV) reported total assets of $5.71B in Q1 2026.
How has Roivant Sciences's total assets changed year-over-year?
Roivant Sciences's total assets increased by 5.0% year-over-year, from $5.44B to $5.71B.
What is the long-term trend for Roivant Sciences's total assets?
Over 5 years (2020 to 2025), Roivant Sciences's total assets has grown at a 17.1% compound annual growth rate (CAGR), from $2.59B to $5.71B.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.